Literature DB >> 10454234

Myoclonic encephalopathy and diabetes mellitus in a boy.

C Lenti1, E Bognetti, R Bonfanti, E Bonifacio, F Meschi.   

Abstract

We describe an 18-month-old boy with insulin-dependent diabetes mellitus who developed idiopathic myoclonic encephalopathy (dancing eye syndrome) at 26 months of age. The neurological symptomatology (multifocal myoclonus, opsoclonus, ataxia, behavioural disturbance) developed within 10 to 14 days after presentation. Biological, neuroradiological, and scintigraphic examination excluded CNS infectious diseases, intoxication, or tumours. At onset of diabetes mellitus, anti-glutamic-acid decarboxylase (GAD) antibodies were observed, and markedly increased in titre when myoclonic encephalopathy occurred. Corticosteroid treatment resulted in a decrease in anti-GAD autoantibody titres and the disappearance of neurological disturbances. As GAD is expressed both in pancreatic beta-cells and cerebellar Purkinje cells, it is possible that a common autoimmune disorder in this patient may account for both the diabetes and myoclonic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454234

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  3 in total

1.  Evaluation of positive and negative predictors of seizure outcomes among patients with immune-mediated epilepsy: a meta-analysis.

Authors:  Divyanshu Dubey; Zehra Farzal; Ryan Hays; L Steven Brown; Steven Vernino
Journal:  Ther Adv Neurol Disord       Date:  2016-07-04       Impact factor: 6.570

2.  Alternating skew deviation in association with anti-glutamic acid decarboxylase antibodies.

Authors:  Asim V Farooq; Ketki Soin; Heather E Moss
Journal:  Neuroophthalmology       Date:  2015-05-13

3.  Serum IgG-induced microglial activation enhances neuronal cytolysis via the NO/sGC/PKG pathway in children with opsoclonus-myoclonus syndrome and neuroblastoma.

Authors:  Xu Ding; Wei Yang; Qinghua Ren; Jiajian Hu; Shen Yang; Wei Han; Jing Wang; Xu Wang; Huanmin Wang
Journal:  J Neuroinflammation       Date:  2020-06-16       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.